ACTR-54. OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED INTERVENTION WITH SKULL REMODELLING SURGERY TO MAXIMIZE LEVELS OF TTFIELDS INTENSITY FOR HIGHER TREATMENT BENEFIT - THE OPTIMAL TTF STUDY

Ítems similars

• ACTR-43. OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED SKULL REMODELING SURGERY TO MAXIMIZE TTFIELDS INTENSITY FOR RECURRENT GLIOBLASTOMA – INTERIM ANALYSIS AND SAFETY ASSESSMENT (OPTIMALTTF-1)
  per: Korshoej, Anders, et al.
  Publicat: (2018)
• OptimalTTF-1: Enhancing tumor treating fields therapy with skull remodeling surgery. A clinical phase I trial in adult recurrent glioblastoma
  per: Korshoej, Anders Rosendal, et al.
  Publicat: (2020)
• Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations
  per: Korshoej, Anders Rosendal, et al.
  Publicat: (2018)
• P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)
  per: Korshoej, A R, et al.
  Publicat: (2018)
• EXTH-04. GUIDING PRINCIPLES FOR PREDICTING THE DISTRIBUTION OF TUMOR TREATING FIELDS IN A HUMAN BRAIN: A COMPUTER MODELING STUDY INVESTIGATING THE IMPACT OF TUMOR POSITION, CONDUCTIVITY DISTRIBUTION AND TISSUE HOMOGENEITY
  per: Korshoej, Anders Rosendal, et al.
  Publicat: (2017)